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Summary
The large diversity of cells that comprise the human immune system requires methods that can
resolve the individual contributions of specific subsets to an immunological response.
Microengraving is process that uses a dense, elastomeric array of microwells to generate
microarrays of proteins secreted from large numbers of individual live cells (~104–105 cells/
assay). In this paper, we describe an approach based on this technology to quantify the rates of
secretion from single immune cells. Numerical simulations of the microengraving process
indicated an operating regime between 30 min-4 h that permits quantitative analysis of the rates of
secretion. Through experimental validation, we demonstrate that microengraving can provide
quantitative measurements of both the frequencies and the distribution in rates of secretion for up
to four cytokines simultaneously released from individual viable primary immune cells. The
experimental limits of detection ranged from 0.5 to 4 molecules/s for IL-6, IL-17, IFNγ, IL-2, and
TNFα. These multidimensional measures resolve the number and intensities of responses by cells
exposed to stimuli with greater sensitivity than single-parameter assays for cytokine release. We
show that cells from different donors exhibit distinct responses based on both the frequency and
magnitude of cytokine secretion when stimulated under different activating conditions. Primary T
cells with specific profiles of secretion can also be recovered after microengraving for subsequent
expansion in vitro. These examples demonstrate the utility of quantitative, multidimensional
profiles of single cells for analyzing the diversity and dynamics of immune responses in vitro and
for identifying rare cells from clinical samples.
Introduction
Identifying clinical markers that correlate with a protective response to a vaccine or that
indicate the efficacy of a treatment for a disease remains a significant challenge. Distinct
functional responses, such as the secretion of one or more cytokines or the proliferative
*Correspondence should be addressed to: J. Christopher Love, Ph.D., Department of Chemical Engineering, Massachusetts Institute of
Technology, 77 Massachusetts Ave., Bldg. 66-456, Cambridge, MA 02139, Phone: 617-324-2300, Fax: 617-258-5042,
clove@mit.edu.
NIH Public Access
Author Manuscript
Lab Chip. Author manuscript; available in PMC 2011 July 2.
Published in final edited form as:
Lab Chip. 2010 June 7; 10(11): 1391–1400. doi:10.1039/b926849a.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
capacity of a cell, can distinguish unique subsets of lymphocytes that may be associated with
the quality of an immune response.1 Resolving heterogeneities among subsets of cells would
be aided, however, by analytical methods that yield multiple measures of the breadth and
quality of functions exhibited by individual lymphocytes.2
Existing analytical methods can assess the frequencies, magnitude, and number of cytokines
produced by individual cells, but not in a comprehensive manner. That is, there are few if
any assays that assign multiple functional and phenotypic characteristics to the same
individual cells without affecting their viability or responses, or requiring surrogate markers
for their activity. Enzyme-linked immunospot (ELISpot) assays are a common method for
measuring the frequencies of primary immune cells producing specific proteins such as
cytokines after stimulation in vitro.3 The technique relies on capturing secreted proteins
using high-affinity antibodies immobilized on a surface close to individual secreting cells
and subsequent detection by a colorimetric, enzymatic reaction. Quantifying the subtle
differences among responding cells within a population is difficult, however, for several
reasons: 1) individual spots vary in size and may overlap; 2) these assays typically require
extended incubations over 12–48 h to detect cytokine-secreting cells, thus limiting the
temporal resolution of responses; 3) conventional colorimetric detection restricts the number
of concurrent proteins detected; and 4) the cells are lost during the process, thereby
hindering further phenotypic analyses. The use of fluorescently-labeled antibodies has
expanded the number of secreted factors that can be detected simultaneously,4–6 but these
modifications have not decreased the minimum time required to detect secreted cytokines
(6–18 h). For antibody-secreting cells (ASCs), the intensities of spots generated in
colorimetric and fluorescent ELISpots have been used to assign rates of secretion after long
periods of incubation.7, 8 Whether these approaches can be used to determine the rates of
secreted cytokines is not clear: ASCs produce significantly more protein than most cytokine-
secreting cells (≪100 molecules/s), and the standards used for comparison in the
colorimetric assays are highly non-linear within the range of detection most relevant for
cytokines.
The combination of intracellular staining (ICS) and multiparameter cytometry has become a
common alternative to assess the number and magnitude of cytokines expressed by single
cells.9, 10 Cells are stimulated for 4–6 h in the presence of inhibitors that block secretion,
and then fixed, permeated, and labeled with antibodies specific for the accumulated
intracellular proteins of interest. Mean fluorescence intensities (MFI) of these labels
measured by flow cytometry or imaging cytometry provide a relative measure of the
quantity of a protein trapped intracellularly.11, 12 Using these values to quantify expression
is challenging, as there is not a suitable standard for converting the measured values into
precisely quantifiable amounts of cytokine. Thus, it is difficult to compare the magnitude of
responses directly among independent samples. Furthermore, ICS measures only the
productive capacity of a cell when prohibited from secretion. This imposed perturbation may
alter the responses of the cells and may not accurately reflect the quantities of cytokine that
would have been secreted by the cell.13 Two modified approaches for flow cytometry—
‘artificial receptors’ and microbeads14–16–allow the capture of secreted cytokines near the
extracellular surface of the cell. Analytical models for the mass transport in these two
processes indicate, however, that the rate of diffusion of released cytokines into the bulk
media limits the sensitivity of these measurements for poor secretors and may introduce
cross-contamination among cells.17 Encapsulation of cells at cold temperatures in polymeric
matrices may also perturb secretion, and requires additional processing to recover them.
Analytical tools for fast (< 6 h) and multiplexed determination of secreted proteins from live
primary cells would help resolve the dynamic behaviors of individual cells following
stimulation, and minimize external perturbations that could unintentionally alter their
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behaviors. Arrays of microwells have been manufactured using a range of materials to
facilitate the isolation and interrogation of single cells.18–27 We previously developed a
technique, called microengraving, that uses an elastomeric array of microfabricated wells to
confine individual viable cells temporarily in subnanoliter volumes, and subsequently, to
generate microarrays of proteins secreted from each cell.28–31 A glass substrate defines one
internal surface of the volumes, and supports an antibody to capture specific proteins
secreted from the cell (Fig. 1a and Fig. S1). After incubation, the glass bearing captured
proteins is removed and interrogated by applying fluorescent antibodies. This process has
made it possible to measure the frequency of cells secreting specific proteins after short
periods of incubation (~3–120 min). Release of proteins over time into the small volumes of
media (~100 pL) surrounding each confined cell allows the sensitive detection of even poor
secretors, such as primary cytokine-secreting cells. The steady accumulation of protein on
the surface over time during this process suggested that it should be possible to calculate the
average rates of secretion for each cell. Here, we used numerical simulations to determine
the optimal ranges of conditions for quantifying protein captured from individual cells, and
then, show quantification of the rates of secretion for as many as four cytokines in parallel
for ~104–105 single primary human lymphocytes. This additional analytical dimension
improves the distinctions between responses induced in primary lymphocytes following
stimulations in vitro by assigning both a frequency and magnitude to responding cells. To
further demonstrate the utility of this system for integrative single-cell analysis, we also
show that measuring specific secretory profiles can guide the identification and retrieval of
T cells for expansion in vitro.
Mathematical model
To analyze the dynamics of capturing analytes during microengraving, we developed a
numerical model that accounts for the secretion of proteins from cells, the diffusion of those
proteins in a confined volume, and the binding of those proteins onto a surface bearing
antibodies with specific affinities for the secreted analytes. The model describes a single cell
confined in a cubic container (50 μm in each linear dimension) that comprises a bottom and
four sidewalls manufactured in poly(dimethylsiloxane) (PDMS) and a top defined by a glass
surface. In the simplest embodiment of the model, the glass surface forming the top of the
reactor supports capture antibodies specific for only one analyte (Fig. 1a).
We made three assumptions that simplified the model and subsequent numerical
simulations. First, the transport of analytes in the media results only from diffusion because
there is no active flow or exchange of fluids in the sealed microwells during incubation.
Second, we assumed that the PDMS walls were impermeable to analyte and that the
adsorption of analyte on these surfaces contributed negligibly to the capture of proteins. For
microengraving, the PDMS is typically treated with a buffered solution containing bovine
serum albumin (BSA) or culture media with 10% bovine serum prior to depositing cells into
the wells.32 These treatments may not eliminate non-specific adsorption completely, but
non-specific capture on BSA/serum-treated PDMS should be significantly lower than the
specific capture on the glass slide. We, therefore, considered this interaction to be negligible
in the model. Finally, we assumed proteins were secreted from the cell at a constant rate (κ).
The total quantity of protein released from the cell in the volume of the reactor, therefore,
increases monotonically with time:
(1)
where Ntotal is the total number of molecules secreted from the cell, κ is the rate of secretion,
and t is the incubation time. The rate of secretion for a live cell likely fluctuates somewhat in
Han et al. Page 3
Lab Chip. Author manuscript; available in PMC 2011 July 2.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
time depending on extrinsic factors such as the quality of its environment as well as intrinsic
factors such as its secretory capacity and its state in the cell cycle.33 Nevertheless, the
assumption of a constant rate in this model is useful for understanding the relationship
between the amount of protein secreted and the amount captured on the glass surface at any
point in time.
The model comprises two equations that describe the diffusion of proteins from the secreting
cell and their capture onto the functionalized surface. The equation for the diffusion of
protein inside the volume of a closed well is:
(2)
where C is the concentration of analyte in the media and D is the diffusion coefficient of
analyte. The reaction of the secreted analyte with the capture antibody supported on the
glass surface is described by a reversible process:
The boundary condition describing the dynamics of adsorption and desorption of the
proteins on the glass surface, therefore, is:
(3)
where kon is the rate of association, koff is the rate of dissociation, Cs is the concentration of
analyte:antibody complex on the glass surface, θ0 is the density of total binding sites on the
surface. θ0-Cs describes the density of remaining binding sites available on the surface. In
the experimental protocols for microengraving, the surface of an array of microwells
containing cells is rinsed with fresh media immediately before sealing the array against the
glass slide. This process dilutes the volume of each well by > 105 fold. Therefore, we
assume the concentrations of protein both in solution and on the surface are initially
negligible (C=0, Cs=0, and θ=θ0 at t=0).
The parameters describing the biophysical properties of the cells and the proteins of interest
were determined from typical values reported in the literature. Lymphocytes range in
diameter from ~5 μm to 20 μm, and proteins of interest (cytokines ~ 15–45 kDa and
antibodies ~ 150 kDa) exhibit diffusion coefficients of 10−9–10−11 m2/s.17, 34 In this model,
we fixed the diameter of the cell and the diffusion coefficient of the analyte (D) to 10 μm
and 10−10 m2/s, respectively. For the binding affinity of the antibody and the rate of
secretion, we tested a range of different values in the model based on similar values reported
previously in the literature.17, 35, 36 The values of parameters used in the simulations
described here are listed in Table 1.
Experimental
Numerical simulations
COMSOL Multiphysics 3.3 (COMSOL AB. Stockholm, Sweden) was used to solve the
partial differential equations relating the secretion, diffusion, and binding of analytes with a
specific capture antibody.
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Preparation of poly-L-lysine slides
Poly-L-lysine slides were prepared according to published protocols available online
(http://cat.ucsf.edu/pdfs/PolylysineSlides.pdf). Briefly, 3″×1″ glass slides (Corning) were
cleaned in 2.5 M NaOH in 60% ethanol for 2 h. After thoroughly washing with deionized
water, slides were submerged in 0.001% poly-L-lysine solution (diluted in 0.1×PBS) for 1 h.
Coated slides were further washed with water, dried, and stored in a desiccator until use.
Immobilization of capture antibodies
Antibodies for capturing secreted proteins were diluted in a buffer comprising 50 mM
sodium borate, 8 mM sucrose, and 50 mM NaCl (pH 9.0) to a final concentration of 10–50
μg/mL, and deposited on the surface of poly-L-lysine slides for at least 1 h at 25 °C. Slides
were then placed in non-fat milk (3% w/v in PBS) for 30 min at 25 °C, washed three times
with PBS, dipped in water, and spun dry.
Estimation of the available binding sites on glass
To estimate the number of binding sites available on a glass slide after adsorbing a capture
antibody from solution, we used a fluorescent, sandwich-style assay to evaluate the
saturating quantity of analyte immobilized on the surface. Briefly, a capture antibody (50
μg/mL) was spotted on the surface of poly-L-lysine slides (1 μL/spot ) and incubated for 1 h
at 25 °C. After blocking and washing the surface, the slide was placed in a 96-well
Microplate Microarray Hardware (ArrayIt, MMH96) and 100 μL of recombinant antigen
(100 ng/mL; e.g., IFNγ) was added on each spot. The dose was selected to saturate the
capture antibody fully, as determined by serial dilution on similar arrays. After a 2 h
incubation at 37 °C, the slide was washed, and a fluorescently labeled detection antibody
(10μg/mL) was applied at 25°C. The labeled slide was then scanned, and the amount of
detection antibody was calculated by comparison with data collected from a standard slide
on which known amounts of the detection antibody were spotted. This experiment yielded
an order-of-magnitude estimate of the number of binding sites available on the glass.
Microengraving
The experiments were performed as previously described with some modifications as
noted.28, 29 Briefly, an array of microwells was manufactured by injecting a silicone
elastomer (polydimethylsiloxane, PDMS; 10:1 base:catalyst; Dow Corning) into a custom-
built mold and cured at 80 °C for 1 h. The arrays were 1 mm thick and adhered directly to a
3″×1″ glass slide. Each array consisted of 72×24 blocks that each contained a 7×7 array of
microwells (50 μm × 50 μm × 50 μm, with a center-to-center distance of 100 μm).32 After
exposing an array to an oxygen plasma for 30 s (Harrick PDC-32G), a cell suspension
(~2×105/mL) was placed on the surface of the array, and the cells were allowed to settle into
the wells by gravity at a density of ~1 cell per well (Fig. S1). After washing excess cells
from the surface of the array with serum-free media, the loaded device was then placed onto
a glass slide coated with capture antibodies. The combination of the array and glass slide
was held together under sufficient compression in a hybridization chamber (Agilent
Technologies, G2534A) to avoid leakage or contamination between wells32 and incubated at
37 °C with 5% CO2. After incubation, the glass slide was separated from the array and
placed in PBS.
Analysis of printed microarrays
After microengraving, slides were incubated with 1% non-fat milk in PBST (PBS with
0.05% (v/v) Tween 20) for 15 min, washed three times with PBST, and then incubated with
fluorescent antibodies (1 μg/mL) for 45 min at 25 °C. Finally, the slides were washed with
PBST and PBS three times each, rinsed briefly with water, and spun dry. Reference slides
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were made at the end of each experiment with the same detection antibodies used on the
printed slides. Antibodies were diluted in water and spotted onto blank poly-L-lysine slides
(1 μL/spot). The reference slides then were dried under vacuum. Slides probed with
fluorescent dye and reference slides were scanned using a Genepix 4200AL microarray
scanner (Molecular Devices). The accompanying commercial software (Genepix Pro 6.1)
was used to extract the MFI of each spot. These data were filtered to remove spots that
contained saturated pixels (%Sat. > 0) or that exhibited a high degree of covariance (CV >
60).
Hybridoma culture and IgG detection
Hybridoma cells HYB 099-01 (Anti-ovalbumin, Statens Serum Institute) were cultured at 37
°C in a 5% CO2 incubator in DMEM Media (Mediatech) supplemented with 10% FBS
(PAA Laboratories), 100 U/mL penicillin, 100 mg/mL streptomycin, 10 mM HEPES, 50 μM
2-mercaptoethanol, 1 mM sodium pyruvate and 0.1 mM nonessential amino acids. The
cultures were split every 2–3 days to maintain a density of 105–106 cells/mL. Poly-L-lysine-
coated glass slides were coated with a mixture of two secondary antibodies: goat anti-mouse
IgG from Zymed (81-6500) and Southern Biotech (1010-01), 50 μg/mL of each. Three
arrays of microwells were loaded with hybridoma cells from the same culture and used for
microengraving for 15, 30, and 45 min. After microengraving, live cells were stained by
adding 1 μM of Calcein violet AM (Invitrogen) on top of the microwells for 20 min;
exposure to light was minimized during this step. The arrays of cells were then imaged. The
antibodies captured on the glass slides were labeled with ovalbumin-Alexa 555 (Invitrogen,
2 μg/mL).
Human peripheral blood mononuclear cells (PBMCs) isolation and stimulation
Venous blood was drawn from healthy controls into green-capped, lithium heparin tubes
(Kendall) with institutional Internal Review Board Approval. PBMCs were separated using
density centrifugation on Ficoll-Paque PLUS (GE Healthcare). PBMCs were frozen at a
concentration of 1–2×107/mL in 10% dimethylsulfoxide (Sigma-Aldrich)/90% fetal calf
serum (Atlanta Biologicals). After thawing, the PBMCs were washed in PBS and
resuspended at 106/mL in RPMI 1640 medium (Mediatech), supplemented with 10% FBS, 2
mM L-glutamine, 10 mM HEPES, 100 U/mL penicillin, 100 mg/mL streptomycin, 0.1 mM
non-essential amino acids, and 1 mM sodium pyruvate. To stimulate IL-6 secretion,
lipopolysaccharide (LPS) (10 μg/mL), phytohemagglutinin (PHA) (5 μg/mL), or pokeweed
mitogen (PWM) (5 μg/mL) was added to cells in round bottom 96-well microtiter plates and
then incubated at 37 °C with 5% CO2. To detect IL-17, IFNγ, IL-2, and TNFα, cells were
stimulated by phorbol 12-myristate 13-acetate (PMA) (10 ng/mL) and ionomycin (1 μg/mL)
for 6 h.
IL-6 detection from PBMCs
Poly-L-lysine slides were coated with 40 μg/mL mouse anti-human IL-6 (MAB206, R&D)
and 10 μg/mL goat anti-human IgG (81-7100, Invitrogen). Human PBMCs were stained
with Calcein violet AM before loading onto the array. After depositing cells onto the array,
the cells were imaged by automated epifluorescent microscopy under temperature and CO2
control. During image collection, stimuli were included in the media and the array of wells
was covered with a Lifterslip (Electron Microscopy Sciences). The array of wells was then
rinsed gently with media containing a trace amount of human serum (1:40,000) (to label the
locations of all microwells with human Ig) and immediately applied onto a glass slide pre-
coated with capture antibodies for 2 h. A portion of the cells used in these experiments were
also stimulated in bulk, and then collected for mRNA quantification by real-time PCR at
intervals matched to the microengraving. Alexa Fluor 488 (A20000, Invitrogen) labeled goat
anti-human IL-6 (AF-206-NA, R&D) and Alexa Fluor 700 (A20010, Invitrogen) labeled
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goat anti-human IgG (109-175-098, Jackson Immune Research) were used for detection. To
assess surface-expressed markers present on the cells after microengraving, 10 μg/ml of
CD3-Alexa Fluor 488, CD11b-Alexa Fluor 568, and CD14-Alexa Fluor 660 were added on
the array of wells. After 30 min incubation in 4°C, the array of wells was washed by PBS
and re-imaged.
Real-time PCR
RNA from PBMCs was purified using the absolutely RNA microprep kit (Stratagene).
cDNA was made using a Taqman kit with supplied random hexamers (Applied Biosystems).
The β2-microglobulin (B2M) and IL-6 primers and probe were obtained from Applied
Biosystems and used according to recommended methodologies. The IL-6 gene expression
is shown relative to B2M.
Multiplexed detection of cytokines
Pairs of antibodies used for multiplex cytokine detection were: IFNγ (MABTECH), IL-17
(eBioscience), IL-2 (R&D), and TNFα (BD). All the detection antibodies were labeled by
Alexa Fluor-NHS esters according to manufacturer’s instructions (Invitrogen). For capture,
10 μg/ml of each capture antibody was used to coat the poly-L-lysine slides. PBMCs were
stained with Calcein violet AM before loading onto the array and imaged in media
containing the applied stimuli. The array of wells was then washed with serum-free media
and immediately applied onto a glass slide pre-coated with capture antibodies. After printing
for 2 h, a solution of labeled antibodies—IL-17 (Alexa Fluor 488), IFNγ (Alexa Fluor 555),
IL-2 (Alexa Fluor 594), TNFα (Alexa Fluor 700)—were used for detection.
Imaging and enumeration of cell-loaded arrays
All images were acquired on an automated inverted epifluorescence microscope (Zeiss)
equipped for live-cell imaging (temperature and CO2 control). The arrays were mounted
face-up on the microscope with a coverslip placed on top of the array. Transmitted light and
epifluoresence micrographs were collected block-by-block (7×7 microwells per block). The
resulting collection of images was analyzed using a custom software program to determine
the number of cells present in each well.
Primary cell retrieval and cloning
Memory T cells and monocytes were bead isolated using negative selection (Miltenyi
Memory CD4+ T Cell Isolation Kit and Monocyte Isolation Kit II). Memory T cells and
monocytes were combined in a 1:1 ratio in the presence of LPS (100 ng/mL) and anti-CD3
(OKT3 1 μg/mL) in HL-1 media and 10% fetal calf serum for 3 days before being deposited
on the array of microwells and analyzed for IL-17 and IFN-γ secretion (2 h). The array of
microwells was incubated in culture media supplemented with 20 U/mL IL-2 for 2 days
after microengraving. Cells that exhibited IFNγ or IL-17 secretion in individual microwells
were retrieved following a previously described protocol.32, 37 Briefly, cytokine-secreting
cells were retrieved from microwells using an automated system for micromanipulation
(CellCelector, AVISO GmbH) equipped with a drawn glass capillary (50-μm diameter).37
Retrieved cells were deposited into a round bottom 96-well microtiter plate containing
irradiated PBMCs used as feeder cells for clonal expansion in the presence of PHA and
IL-2. After two weeks, proliferated clones were collected, stimulated with PMA and
ionomycin in the presence of monensin (BD GolgiStopT, BD Bioscience) and interrogated
for cytokine expression by ICS.
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Data analysis
The data extracted from both the array of cells and the matching printed microarrays were
matched in Excel (Microsoft) using unique identifiers assigned to each well within the array.
The dataset was filtered to include the locations in the array that contained only single cells
matched to secreted proteins on the corresponding microarray for subsequent analysis in
Excel or MATLAB (The Mathworks, Natick, MA). To convert the measured MFI for the
cytokines captured from a given cell into a rate of secretion, we used a series of known
amounts of fluorescent detection antibodies arrayed on a glass slide as a reference to
translate MFI into a finite quantity of captured analyte (assuming a 1:1 relationship between
the captured cytokine of interest and the detection antibody as rationalized below); dividing
this number of molecules by the time of incubation yielded the average rate of secretion for
a given cell. Box plots follow Tukey’s convention, with the center line representing the
median, and the upper and lower edges of the box representing the values of the upper and
lower quartiles. Whiskers extending from each end of the box represent the most extreme
values within 1.5 times the interquartile range.
Results and discussion
Modeling the capture of protein secreted from confined cells
To determine how secreted proteins distribute over time in the media surrounding a confined
cell and onto the binding surface during microengraving, we executed a series of numerical
simulations using our mathematical model for the diffusion and capture of proteins. These
calculations suggested that the process involves three characteristic temporal regimes (Fig.
1b). Immediately after sealing the cell inside a well, the concentration of proteins in solution
exceeds that present on the surface. After a short time (~30 min for a cell secreting 10
molecules/s), a steady–state distribution of protein is reached in solution, varying from a
high concentration around the cell to a low concentration at the surface of the glass. (We
note that this steady-state distribution is reached at approximately the same point in time
regardless of the choice of the diffusion coefficient for the protein (10−9–10−11 m2/s).) In
the ensuing period of time, the protein accumulates predominantly on the surface rather than
in solution: The quantity of protein captured on the surface increases at a rate reflecting the
rate of secretion from the cell (dNsurface/dt~κ), while the concentration of proteins in the
media remains nearly constant. Eventually, the quantity of analytes on the surface
approaches the total number of available binding sites on the surface (Cs~θ0). At this point
(> 27 h), the rate of capture at the surface decreases, and the concentration of analytes in the
media increases, rapidly approaching the total concentration of protein secreted.
Effects of system parameters on the capture of analytes
The simulations indicated that the intermediate temporal regime (t ~ 30 min to 27 h)
represents the ideal period to measure the average rates of secretion for each cell in the
array. The viability of mammalian cells in the sealed microwells, particularly primary cells,
declines significantly after 4–6 h; this constraint establishes the practical upper bound on the
length of time that is feasible for microengraving to less than 4 h.28, 38 Within this range of
times, we used our model to understand how the affinity (KD) of the capture antibodies and
the number of binding sites available on the surface (θ0) may influence the quantity of
analytes captured on the surface. The antibodies used to capture the secreted analytes should
have high affinities (< 10 nM) (Fig. S2a). For an antibody with KD~100 pM, the amount of
protein captured on the surface closely approximates the total amount of protein secreted
during the incubation (Nsurface~95–99% Ntotal). We validated that the commercial antibodies
used in this work to capture specific cytokines each have KD~10–100 pM by ELISA
measurements and data provided by the manufacturers.
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The calculations also showed that increasing θ0 improves the accuracy of the quantity
captured (Fig. S2b). The optimal range calculated for θ0 (~10−9-10−8 mol/m2) is consistent
with the typical saturating densities measured for antibodies immobilized on hydrophilic
surfaces (glass) from buffered solutions by optical reflectometry,39, 40 surface plasmon
resonance,41 and spectroscopic ellipsometry,42 and with our own measurements of the
saturating quantity of antigen captured on the glass slides used here. For short times of
incubation (30 min-4 h), the model suggested that the fraction of binding sites occupied with
cytokines (κ=10 molecules/s) is less than 10%. This low occupancy makes it reasonable to
assume that, under the typical experimental conditions employed for microengraving, the
molar ratio of captured proteins to labeled monoclonal antibodies used for detection is
approximately 1:1.
For a cell secreting at a constant rate, the model predicts the accumulated signal on the
binding surface increases linearly with the rate of secretion. This trend implies that the total
amount of analyte captured by microengraving for a given cell over a fixed period of time is
a measure of its average rate of secretion. Simulations for the number of analytes
accumulated on the surface after a fixed time (2 h) suggest that poor binding affinity for the
capture antibody could lead to an underestimation of the absolute rates of secretion by
approximately twofold (Fig. S2c). Together, these calculations imply that a relatively large
range of operating parameters is possible without affecting the accuracy of the estimated rate
by more than two- to threefold.
Geometric parameters, such as the size and shape of the well and even the position of a cell
within the well, could also impact the diffusion and capture of the analytes. The design and
fabrication of the microarray by replica molding determines the physical geometry of the
wells, but the position of the cell in each well can vary. Through experimental observation,
cells usually settle randomly on the bottom of each well, but they occasionally adhere to the
sidewalls. Our model suggests that the position of the cell within the well influences the rate
at which a steady-state distribution of analytes is reached in solution during the initial stages
of the process, but that it does not affect the predicted range of times for the quantitative
capture on the surface (Fig. S2d). This result implies that the location of the cell inside the
well is not important, and that the signals detected from different wells across the same array
are comparable. These results also indicate that changing the depth of the microwells within
the same order of magnitude does not significantly alter the sensitivity of the assay, but
changing the surface area exposed to the confined volume does. The initial rates of secretion
and capture do not change with decreasing surface area, but the time to saturation decreases
as the total number of binding sites decreases. Decreasing the exposed surface area (for a
cell producing proteins at a constant rate) also increases the density of captured molecules
on the surface (and therefore the total fluorescent signal measured). Therefore, for the same
incubation time, the signal-to-noise ratio increases as the cross-sectional area of the wells
decreases. These calculations suggest that the combination of cross-sectional area and
incubation time will determine the upper and lower limits on the rates of secretion that can
be determined accurately (Fig. S3). The steric crowding of cytokines and antibodies on the
capture surface at high occupancy (~95% θ0) establishes an upper bound on the rates
detected, while the density of captured analytes will affect the lower limit of detection. For
most cytokines (with rates of secretion typically <100 molecules/s), our model suggests the
minimum time required for microengraving to detect 0.5 molecules/s is 1 h for 30 μm × 30
μm wells and 2 h for 50 μm × 50 μm wells. Taken together, the simulations discussed here
indicate that a practical set of operating conditions for microengraving are possible wherein
the rates of secretion for analytes such as cytokines can be detected down to 0.5 molecules/s
within 1–2 h.
Han et al. Page 9
Lab Chip. Author manuscript; available in PMC 2011 July 2.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Experimental validation of predicted dynamics for capturing proteins by microengraving
Our model suggested that the amount of proteins from individual cells captured on a binding
surface should increase monotonically with the time allowed for microengraving. To test
this hypothesis, we measured the quantities of a cytokine (interleukin-6, IL-6) released from
individual PBMCs after stimulation with a Toll-like receptor agonist, LPS, for 48 h. The
median values of the MFI for IL-6 (captured from individual cells) increased linearly with
time (Fig. 2a). This result matched the response predicted by the numerical simulations. The
simulations also indicated that variations in intensities measured following a fixed period of
time for microengraving should increase monotonically with increased rates of secretion.
We used a mouse hybridoma cell line to measure the secretion of IgG by microengraving for
three different periods of incubation, and plotted the median values of MFI as a function of
the number of cells in each well (Fig. 2b). For each fixed period of microengraving, the
quantity of captured IgG increased linearly with the number of cells in each well. These data
establish that the variations in MFI of captured protein at a fixed time point reflect the
variations in the amounts of protein secreted by individual cells, and, therefore, in the
average rates of secretion per cell.
Determination of the rates of cytokine secretion from single cells
The linear relationship between the measured MFIs for captured proteins and the number of
cells per well suggested that microengraving also could efficiently and quantitatively yield
estimates for the amount of protein secreted from single cells within a defined period. We
stimulated human PBMCs with LPS for 3, 6, and 12 h, and then captured IL-6 by
microengraving. In parallel, we prepared a standard reference comprising known amounts of
fluorescent detection antibodies (Fig. S4). Using this reference to convert the measured MFI
for the captured cytokines into amounts, we determined the distribution in the individual
rates of secretion for IL-6 among the population of cells (Fig. 3a). The limit of detection was
defined as the rate of secretion corresponding to three standard deviations above the median
MFI of the average background on the array. For IL-6, this limit was 0.6±0.1 molecules/s
(when using 50 μm wells for microengraving with an incubation time of 2 h); the limits of
detection determined for other cytokines were also similar (Table 2). This sensitivity
exceeds that of antibody-based capture at the surfaces of secreting cells by nearly two orders
of magnitude.17 Based on the propagation of the uncertainties contributed both by
approximations from our simulations and by the error of measurements in the experiment,
we calculated that the uncertainty for the rate of secretion measured from a given cell is
about 18%. The uncertainty of the measured area of individual elements on the microarray
generated by microengraving (16%) was the dominant source of error because the spatial
resolution of the scanner employed (5 μm) significantly limited the precision of this
measure.
The measured responses showed that the frequency of IL-6-secreting cells (number of IL-6-
secreting cells within the total population) increased with time, especially between 3 and 6h,
and that the mean rate of secretion per cell increased monotonically from 6.5±3.2 (3 h) to
10.6±7.1 (12 h). This range of values is consistent with that estimated by ELISA (using the
supernatents from the stimulated cells), and reported values in the literature for cytokine
release from primary cells.43 The expression of mRNA encoding IL-6, however, peaked at 6
h (Fig. 3b). This observation indicates, as expected, that the timing of transcription does not
necessarily correlate with the timing for secretion of a protein. To assess whether the most
productive cells were derived from a particular subset of cells within the PBMCs, the cells
were labeled and then imaged in situ after microengraving. Most of the cells secreting IL-6
were CD11b+CD14− (45%, 10±8.4 molecules/s) and CD11b+CD14+ (27%, 10±7.4
molecules/s), while a small population of cells were CD3+ (4.7%, 12.5±9.4 molecules/s)
(Fig. 3a insert and Table S1). Since CD11b and CD14 are markers predominantly associated
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with monocytes, this result is consistent with previous reports that show LPS strongly
mediates monocytes responses.44, 45 The median rates of secretion for each class of cells,
however, did not differ significantly (two-tailed, unpaired Student’s t-test), suggesting the
magnitudes of reponses to the applied stimulus of LPS for these different lineages of cells
are all similar.
The combination of the frequency of responding cells and the distributions in their rates of
secretion should facilitate distinguishing differences in the magnitude of functional immune
responses after stimulation. We tested whether the distributions of rates of IL-6 secretion
could differentiate responses between two individuals after exposing their PBMCs to three
different stimuli. The responses of cells from the same donor exhibited strong variations in
both frequency and magnitude (rates) depending on the stimulation, and this combination of
responses was unique to the individuals (Fig. 3c). Both donors exhibited similar frequencies
of responding cells when stimulated with PHA, but the distributions in the rates of secretion
were quite different. Kolmogorov-Smirnov statistical tests of the distributions indicated that
only two conditions of stimulation (LPS and PHA for Donor 2) were similar (p=0.8622).
These results demonstrate that assays that distinguish immune responsiveness based on
multiple, independent measures (frequencies and rates) may be more robust than those
relying on single-parameter measures (frequencies).
Multiplexed detection of cytokines from single cells
The analysis of multiple cytokines concurrently is important for distinguishing different
functional responses among lymphocytes, and for realizing robust clinical assays where
samples are limited in size. We next extended the number of cytokines for which the rates of
secretion could be analyzed simultaneously during microengraving. Our analytical model
suggested that up to 10 individual antibodies within a mixed adsorbed layer could operate
independently to capture different analytes from the same cell without affecting the
individual limits of detection, assuming sufficient specificities for each pair of antibodies
used for capture and detection. We tested commercial pairs of antibodies for IL-17, IFNγ,
IL-2, and TNFα to determine a combination that exhibited no significant (< 3%) cross-
reactivity at the maximum concentrations of cytokines relevant for microengraving (~10 ng/
mL). To demonstrate the multiplexed analysis of cytokines by quantitative microengraving
using this panel, we characterized the distributions in the rates of cytokines released from
human PBMCs following stimulation with PMA and ionomycin. Representative images of
viable single cells in microwells that produced up to three different cytokines within 2 h are
shown in Fig. 4a. These results show that different cytokines can be detected simultaneously
with this assay, and thus, the rates of secretion for each cytokine can be determined
independently (Fig. 4b). We found that the release of IFNγ was the most dynamic (3.8–120
molecules/s), while the rates for other cytokines were typically less than 20 molecules/s.
IFNγ and IL-2+ cells included both CD4 and CD8 T cells: Although the frequencies of each
lineage differed, the distributions of their rates of secretion were similar (Fig. 4c). Together,
these results show that multiple secreted factors can be scored quantitatively in parallel for
individual cells within a heterogeneous population.
Retrieval of primary T cells for in vitro expansion
Microengraving is a sufficiently rapid and efficient process that individual cells remain
viable, and can be retrieved afterwards from the microwells in which they are isolated.28, 32
This characteristic implies that clonal lines of T cells or other primary lymphocytes could be
generated on the basis of their functional profiles (e.g., secreted cytokines)—a criterion for
selection of clones that is not possible by traditional ELISpot or ICS. To test whether
primary T cell lines could be generated from their cytokine profiles determined by
microengraving, we retrieved cells secreting either IL-17 or IFNγ from 50 μm wells after
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microengraving and cultured them in 96-well microtiter plates containing irradiated PBMCs,
PHA, and IL-2 to promote proliferation and expansion. After two weeks in culture, most of
the retrieved cells had proliferated (>80 % efficiency). The cytokine profiles of these clones
were then analyzed by ICS for IL-17 and IFNγ. After expansion, the majority of cells in
each population still kept their original profiles of cytokine production; two examples are
shown in Fig. 5. These results demonstrate that incubation of primary T cells in closed
microwells for a short time (~2 h) does not change their viability, and that those cells can be
specifically retrieved for expansion and for subsequent characterization by other analytical
methods.
Conclusions
The quantitative extension to microengraving described here now makes it possible to
categorize a population of viable lymphocytes on the basis of three independent attributes:
1) surface-expressed markers indicating their immunophenotypes, 2) the frequencies of cells
secreting cytokines, and 3) the rates of secretion of those cytokines. Such multidimensional
profiles of individual cells should improve the differentiation of heterogeneous subsets of
cells that are crucial for evaluating vaccine responses and understanding the pathology of
chronic diseases. The small volumes required for dispensing a population of cells onto an
array of microwells makes the approach especially well-suited for detailed, quantitative
characterization of clinical samples where the number of cells available may be insufficient
for analysis by independent conventional methods (e.g., infants, tissue biopsies). The results
from the analytical model, confirmed by experimental data, also emphasize a technical
advantage associated with temporarily confining cells into small volumes that contain an
appropriate capture reagent for one or more analytes of interest. In contrast to ELISpot,
ELISA, and related adaptations of these conventional immunoassays implemented in open
arrays of microwells,18, 46 the non-equilibrium conditions for mass transport achieved by
confining secreting cells significantly reduce the time required to detect specific analytes,
and enhance the sensitivity of the assay to low quantities of released proteins. Finally, the
ability to identify and recover cells of interest based on their functional attributes (e.g.,
profile of cytokine secretion) by quantitative microengraving provides a unique capability
for further evaluating the heterogeneities among various clonotypes that is not possible by
conventional ELISpot or ICS. Together, the combination of these characteristics suggests
that quantitative, multiplexed microengraving should enable dynamic studies of the
functional responses of individual primary lymphocytes following stimulation with new
temporal resolution. Such measurements would allow detailed analyses of human
lymphocytes that cannot be followed presently for individual cells—e.g., the plasticity of T
cells and the timing of cytokine release from individual immune cells.
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Figure 1.
Analysis of mass transfer and distribution of analytes during microengraving. (a) Schematic
of the configuration of one microwell containing a single cell during microengraving. (b)
Plot of the calculated quantity of analytes accumulated in the media (○) and on the surface
of the glass (●) during microengraving when the cell secretes at a constant rate of 10
molecules/s. The solid line indicates the cumulative quantity of analytes secreted by the cell
over time. For this simulation, the affinity of the capture antibody was KD=100 pM, and the
density of binding sites on the surface was θ0=10−9 mol/m2.
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Figure 2.
Single-analyte measurements using microengraving. (a) Measurement of IL-6 secreted by
individual human PBMCs. Boxplot of relative MFI of captured IL-6 as a function of
incubation time. n is the number of events in each box. The solid line was fit by linear
regression of the median values. Statistics were determined by a two-tailed Student’s t-test.
(b) Measurement of the secretion of antibodies from mouse hybridoma cells. The relative
MFI of the signals were plotted as a function of the number of cells contained in each well
for three different incubation times (15, 30, and 45 min). Solid lines were fit by linear
regression. n is the number of events of each box.
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Figure 3.
Quantification of the frequencies and rates of secretion for single cells producing IL-6. (a,b)
Production of IL-6 by human PBMCs following stimulation with LPS for 3, 6, or 12 h. (a)
Histograms of the distribution of rates of secretion of IL-6 measured by microengraving (2
h) as a function of the time allowed for stimulation (3 h, green; 6 h, red; 12 h, blue). Insert:
A plot of the specific rates of secretion determined for different subsets of cells within the
array after 6 h stimulation. Horizontal bars indicate the mean value for each group. (b)
mRNA levels of IL-6 measured by quantitative PCR post-stimulation. (c) Histograms of the
distribution of rates of secretion of IL-6 from PBMCs from two donors measured by
microengraving (2 h) following stimulation with LPS, PHA or PWM for 24 h. The values n
Han et al. Page 17
Lab Chip. Author manuscript; available in PMC 2011 July 2.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
indicated in (a) and (c) are the normalized frequencies of responding cells for each
condition.
Han et al. Page 18
Lab Chip. Author manuscript; available in PMC 2011 July 2.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 4.
Quadriplexed analysis of cytokines secreted from single cells. Human PBMCs were
stimulated with PMA and ionomycin for 6 h, followed by microengraving for 2 h. (a)
Representative images of individual cells in microwells matched with micrographs from the
corresponding microarray of cytokines (arranged in rows). The first column shows
composite micrographs of microwells (phase contrast) and viable cells (Calcein AM). The
remaining four columns are micrographs extracted from the matching location on the printed
microarray for each of four cytokines (IL-17, blue; IFNγ, green; IL-2, yellow; TNFα, red).
Orange boxes outside the images indicate the positive spots in each row (MFI > background
+ 3SD). (b) Histograms of the calculated rates of secretion for each group of cytokine-
producing cells. The colors are consistent with the assignments in (a). The inset rows of
squares in each histogram indicate the combination of cytokines produced by the cells
represented in the plot. The values of n indicated on each histogram are the normalized
frequencies of cytokine-producing cells per 100,000 cells. The histograms were constructed
with data from three independent experiments. (c) Histograms of the rates of secretion
measured for CD4 and CD8 T cells producing IFNγ (top) or IL-2 (bottom). n is the number
of cells imaged after microengraving bearing the indicated surface markers.
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Figure 5.
Recovery and expansion of T cell lines selected by their cytokine profiles. T cells were
stimulated with LPS-activated monocytes and anti-CD3 for 3 days, and then their cytokine
profiles were determined by microengraving (2 h). The cells were cultured in the microwells
for 48 h after microengraving, and then recovered by micromanipulation. The selected cells
were expanded on irradiated PBMCs for 2 weeks, and then characterized by flow cytometry
and intracellular staining. Fluorescent micrographs (top panels) indicate the cytokine profile
measured by microengraving for (a) IL-17 secreting cells and (b) IFNγ-secreting cells. The
number of cells present in both wells at the time of retrieval was four. The scatter plots
(bottom panels) show the results of intracellular cytokine staining detected by flow
cytometry. The expanded cells were stimulated with PMA/ionomycin in the presence of
monensin, then fixed, permeabilized, and stained with antibodies against IFNγ (labeled with
phycoerythrin (PE)) and IL-17 (labeled with allophycocyanin (APC)). Cytometry data were
plotted in the graph according to the fluorescence intensities measured from both channels.
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Table 1
Values of parameters used in simulation
Well size 50 μm×50 μm×50 μm
Cell diameter 10 μm
Diffusion coefficient (D) 10−10 m2/s
Association rate constant (kon) 105–106 M−1 s−1
Dissociation rate constant (koff) 10−3–10−4 s−1
Rate of secretion (κ) 1–100/cell/s
Density of total binding sites (θ0) 10−8–10−10 mol/m2
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Table 2
Experimental limits of detection for five cytokines
Cytokine Fluorophore Limit of detection (molecules/s)
IL-6 Alexa Fluor 488 0.5–0.7
IL-17 Alexa Fluor 488 0.5–0.6
IFNγ Alexa Fluor 555 3.8–4.1
IL-2 Alexa Fluor 594 0.8–3.1
TNFα Alexa Fluor 700 1.8–2.0
The limit of detection was determined for the specific fluorophore used on each detection antibody and defined as three standard deviations (SD)
above the average background.
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